Panbela Therapeutics EV/EBIT
Quel est le EV/EBIT de Panbela Therapeutics?
Le EV/EBIT de Panbela Therapeutics Inc. est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Panbela Therapeutics
Que fait Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Entreprises avec ev/ebit similaire à Panbela Therapeutics
- Radha Madhav a EV/EBIT de N/A
- Acasti Pharma Inc a EV/EBIT de N/A
- Akers Biosciences Inc a EV/EBIT de N/A
- Agios Pharmaceuticals Inc a EV/EBIT de N/A
- Generation Bio Co a EV/EBIT de N/A
- Purple Biotech a EV/EBIT de N/A
- Panbela Therapeutics a EV/EBIT de N/A
- Continental Materials a EV/EBIT de N/A
- GlycoMimetics Inc a EV/EBIT de N/A
- Veritas Pharma a EV/EBIT de N/A
- Impac Mortgage a EV/EBIT de N/A
- Canterra Minerals a EV/EBIT de N/A
- Kinnate Biopharma a EV/EBIT de N/A